Lido Advisors LLC Lowers Position in Cardinal Health, Inc. $CAH

Lido Advisors LLC lessened its stake in Cardinal Health, Inc. (NYSE:CAH) by 25.0% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 43,149 shares of the company’s stock after selling 14,370 shares during the quarter. Lido Advisors LLC’s holdings in Cardinal Health were worth $9,118,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of CAH. Redhawk Wealth Advisors Inc. raised its position in Cardinal Health by 0.5% in the 4th quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock valued at $1,902,000 after buying an additional 48 shares during the last quarter. HF Advisory Group LLC lifted its stake in Cardinal Health by 0.9% during the 4th quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock valued at $1,074,000 after acquiring an additional 49 shares in the last quarter. Kathmere Capital Management LLC boosted its holdings in Cardinal Health by 1.2% during the 1st quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock worth $896,000 after acquiring an additional 49 shares during the last quarter. Hillsdale Investment Management Inc. boosted its holdings in Cardinal Health by 0.9% during the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock worth $1,184,000 after acquiring an additional 50 shares during the last quarter. Finally, V Square Quantitative Management LLC grew its stake in shares of Cardinal Health by 2.6% in the 1st quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock worth $423,000 after acquiring an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Zacks Research downgraded shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Mizuho boosted their price target on shares of Cardinal Health from $235.00 to $240.00 and gave the stock an “outperform” rating in a report on Thursday. UBS Group upped their price objective on shares of Cardinal Health from $260.00 to $274.00 and gave the stock a “buy” rating in a research report on Monday. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 4th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $251.73.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $227.96 on Friday. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $243.21. The firm has a market cap of $53.39 billion, a PE ratio of 34.86, a P/E/G ratio of 1.11 and a beta of 0.49. The stock has a fifty day moving average price of $219.98 and a 200-day moving average price of $214.43.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts anticipate that Cardinal Health, Inc. will post 10.77 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were given a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend was Wednesday, July 1st. Cardinal Health’s payout ratio is presently 31.50%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.